Cleared Traditional

K853031 - JECT-AID

K853031 is an FDA 510(k) clearance for JECT-AID, manufactured by Autoject Systems, Inc.. The device is a Class 2 General Hospital device with product code KZE cleared through the Traditional 510(k) pathway after a 167-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1986
Decision
167d
Days
Class 2
Risk

K853031 is an FDA 510(k) clearance for the JECT-AID. Classified as Injector, Fluid, Non-electrically Powered (product code KZE), Class II - Special Controls.

Submitted by Autoject Systems, Inc. (Hemet, US). The FDA issued a Cleared decision on January 1, 1986 after a review of 167 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5430 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K853031

510(k) Number K853031 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 1985
Decision Date January 01, 1986
Days to Decision 167 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d slower than avg
Panel avg: 129d · This submission: 167d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KZE Device Classification - Class 2, Special Controls

Product Code KZE Injector, Fluid, Non-electrically Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5430
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - KZE Injector, Fluid, Non-electrically Powered

All 52
Devices cleared under the same product code (KZE) and FDA review panel - the closest regulatory comparables to K853031.
BIOJECTOR SYRINGE SYSTEM
K861687 · Bioject, Inc. · Apr 1987
DERATA MEDI-JECTOR IV
K864561 · Derata Corp. · Feb 1987
INJET-100, FLUID INJECTOR
K861582 · Injet Medical Products, Inc. · Feb 1987
MEDAJET XL - JET INJECTOR
K850754 · Mada Medical Products, Inc. · Dec 1985
DERATA MEDI-JECTOR PRO
K844244 · Derata Corp. · Jul 1985
VACUUM COMPRESSION INJECTOR
K851809 · Uci Corp. · Jul 1985